Entera Bio logo

Entera Bio Share Price Today

(NASDAQ: ENTX)

Entera Bio share price is $1.96 & ₹170.46 as on 6 Mar 2025, 2.30 'hrs' IST

$1.96

-0.02

(-1.01%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Entera Bio share price in Dollar and Rupees. Guide to invest in Entera Bio stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Entera Bio, along with analyst recommendations, forecasts, and comprehensive financials.

Entera Bio share price movements

  • Today's Low: $1.90
    Today's High: $1.96

    Day's Volatility :3.06%

  • 52 Weeks Low: $1.30
    52 Weeks High: $3.35

    52 Weeks Volatility :61.19%

Entera Bio (ENTX) Returns

PeriodEntera Bio LtdIndex (Russel 2000)
3 Months
10.61%
0.0%
6 Months
1.54%
0.0%
1 Year
44.53%
0.0%
3 Years
-11.61%
-11.6%

Entera Bio (ENTX) Key Statistics

in dollars & INR

Previous Close
$1.98
Open
$1.9
Today's High
$1.96
Today's Low
$1.9
Market Capitalization
$72.9M
Today's Volume
$19.4K
52 Week High
$3.35
52 Week Low
$1.3
Revenue TTM
$99.0K
EBITDA
$-9.2M
Earnings Per Share (EPS)
$-0.27
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-144.67%

How to invest in Entera Bio Stock (ENTX) from India?

It is very easy for Indian residents to invest directly in Entera Bio from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Entera Bio stock in both Indian Rupees (INR) and US Dollars (USD). Search for Entera Bio or ENTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Entera Bio or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Entera Bio shares which would translate to 0.444 fractional shares of Entera Bio as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Entera Bio, in just a few clicks!

Returns in Entera Bio (ENTX) for Indian investors in Rupees

The Entera Bio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Entera Bio investment value today

Current value as on today

₹1,48,028

Returns

₹48,028

(+48.03%)

Returns from Entera Bio Stock

₹43,066 (+43.07%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Entera Bio (ENTX)

0%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Entera Bio Stock from India on INDmoney has increased by 0% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Entera Bio

    Analyst Recommendation on Entera Bio

    Buy

      85%Buy

      14%Hold

      0%Sell

    Based on 7 Wall street analysts offering stock ratings for Entera Bio(by analysts ranked 0 to 5 stars)

    Based on 7 analyst
    • Current
    • 1M Ago
    • 3M Ago
    Buy
    6
    6
    6
    Hold
    1
    1
    1
    Sell
    0
    0
    0

    Analyst Forecast on Entera Bio Stock (ENTX)

    What analysts predicted

    Upside of 410.2%

    Target:

    $10.00

    Current:

    $1.96

    Insights on Entera Bio Stock (Ticker Symbol: ENTX)

    • Price Movement

      In the last 3 months, ENTX stock has moved up by 10.6%
    • Decreasing Revenue

      Revenue is down for the last 3 quarters, 4.48M → 42.0K (in $), with an average decrease of 62.5% per quarter
    • Decreasing Net Profit

      Netprofit is down for the last 4 quarters, -1.99M → -3.02M (in $), with an average decrease of 16.1% per quarter
    • ENTX vs ALNY (1 yr)

      In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 36.2%
    • ENTX vs VRTX (3 yr)

      In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 55.6%
    • Price to Sales

      ForENTX every $1 of sales, investors are willing to pay $660.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

    Entera Bio Technicals Summary

    Sell

    Neutral

    Buy

    Entera Bio is currently in a neutral trading position according to technical analysis indicators.

    Entera Bio (ENTX) Vs Peers

    Company Name1 Month6 Month1 Year3 Years5 Years
    Entera Bio Ltd logo
    -13.91%
    1.54%
    44.53%
    -11.61%
    -28.0%
    Regeneron Pharmaceuticals, Inc. logo
    1.3%
    -41.29%
    -30.51%
    9.2%
    42.38%
    Beone Medicines Ltd logo
    15.19%
    34.31%
    61.3%
    43.16%
    68.1%
    Vertex Pharmaceuticals Incorporated logo
    3.37%
    3.77%
    18.06%
    106.43%
    121.36%
    Alnylam Pharmaceuticals, Inc. logo
    -11.52%
    -3.4%
    62.32%
    49.04%
    120.93%
    Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
    Entera Bio Ltd logo
    NA
    NA
    NA
    0.0
    -1.45
    -0.71
    NA
    0.18
    Regeneron Pharmaceuticals, Inc. logo
    17.85
    17.85
    1.03
    43.09
    0.16
    0.07
    0.01
    273.57
    Beone Medicines Ltd logo
    NA
    NA
    NA
    1.43
    -0.19
    -0.06
    NA
    31.22
    Vertex Pharmaceuticals Incorporated logo
    32.84
    NA
    1.33
    18.07
    -0.03
    0.13
    NA
    63.87
    Alnylam Pharmaceuticals, Inc. logo
    NA
    NA
    -0.49
    0.57
    -15.01
    -0.03
    NA
    0.52
    Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
    Entera Bio Ltd logo
    Buy
    $72.9M
    -28.0%
    NA
    0.0%
    Regeneron Pharmaceuticals, Inc. logo
    Buy
    $74.9B
    42.38%
    17.85
    31.07%
    Beone Medicines Ltd logo
    NA
    $28.5B
    68.1%
    NA
    -16.92%
    Vertex Pharmaceuticals Incorporated logo
    Buy
    $124.1B
    121.36%
    32.84
    -4.86%
    Alnylam Pharmaceuticals, Inc. logo
    Buy
    $31.5B
    120.93%
    NA
    -12.37%

    About Entera Bio

    Entera Bio Ltd., a clinical stage company, focuses on developing oral peptide or protein replacement therapies for unmet medical needs where an oral tablet form holds the potential to transform the standard of care. The company leverage its N-Tab, an oral delivery technology, which is designed to simultaneously stabilize the peptide in the gastrointestinal tract and promote its absorption into the bloodstream. Its advanced product candidate is EB613 (oral PTH (1-34)) that is entering into Phase 3 development as the first oral, osteoanabolic (bone-building) once-daily tablet treatment for post-menopausal women with low bone mineral density and high-risk osteoporosis. The company is also developing EB612 as the first oral PTH(1-34) tablet peptide replacement therapy for hypoparathyroidism. In addition, it is developing the first oral oxyntomodulin, a dual targeted GLP1/glucagon peptide, in tablet form for the treatment of obesity; and the first oral GLP-2 peptide tablet as an injection-free alternative for patients suffering from rare malabsorption conditions, such as short bowel syndrome. The company has research collaboration agreement with OPKO Biologics, Inc. Entera Bio Ltd. was incorporated in 2009 and is based in Jerusalem, Israel.
    Organization
    Entera Bio
    Employees
    18
    CEO
    Ms. Miranda J. Toledano M.B.A.
    Industry
    Health Technology

    Management People of Entera Bio

    NameTitle
    Ms. Miranda J. Toledano M.B.A.
    CEO & Director
    Ms. Dana Yaacov-Garbeli CPA
    Chief Financial Officer
    Dr. Hillel Galitzer M.B.A., Ph.D.
    Chief Operating Officer
    Dr. Gregory Burshtein Ph.D.
    Chief of Research & Development

    Important FAQs about investing in ENTX Stock from India :

    What is Entera Bio share price today?

    Entera Bio share price today stands at $1.96, Open: $1.90 ; Previous Close: $1.98 ; High: $1.96 ; Low: $1.90 ; 52 Week High: $3.35 ; 52 Week Low: $1.30.

    The stock opens at $1.90, after a previous close of $1.98. The stock reached a daily high of $1.96 and a low of $1.90, with a 52-week high of $3.35 and a 52-week low of $1.30.

    Can Indians buy Entera Bio shares?

    Yes, Indians can invest in the Entera Bio (ENTX) from India.

    With INDmoney, you can buy Entera Bio at 0 brokerage. The step-by-step process is as follows:

    • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
    • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
    • Once funds are transferred successfully, you can buy Entera Bio at zero transaction cost.

    How can I buy Entera Bio shares from India?

    It is very easy to buy Entera Bio from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

    Can Fractional shares of Entera Bio (ENTX) be purchased?

    Yes, you can buy fractional shares of Entera Bio with INDmoney app.

    What are the documents required to start investing in Entera Bio stocks?

    To start investing in Entera Bio, You will need the following documents:

    • Proof of Identification (PAN, Aadhaar etc)
    • Proof of address (Aadhaar, Voter ID etc)

    These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

    What are today’s High and Low prices of Entera Bio Stock (ENTX)?

    Today’s highest price of Entera Bio (ENTX) is $1.96.

    Today’s lowest price of Entera Bio (ENTX) is $1.90.

    What is today's market capitalisation of Entera Bio?

    Today's market capitalisation of Entera Bio ENTX is 72.9M

    What is the 52 Week High and Low Range of Entera Bio Stock (ENTX)?

    • 52 Week High

      $3.35

    • 52 Week Low

      $1.30

    What are the historical returns of Entera Bio (ENTX)?

    • 1 Month Returns

      -13.91%

    • 3 Months Returns

      1.54%

    • 1 Year Returns

      44.53%

    • 5 Years Returns

      -28%

    Who is the Chief Executive Officer (CEO) of Entera Bio ?

    Ms. Miranda J. Toledano M.B.A. is the current Chief Executive Officer (CEO) of Entera Bio.